Please assess the completion status of the following clinical trial:

Trial Title: Endoscopic Surgical Treatment of Rhino-Sinusal Mucormycosis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Man or woman, over 18 years old, presenting a mucormycosis on a sinus biopsy showing large filaments with non or little septae compatible with a mucoral or with a positive culture for a mucoral on a sinus sample associated to clinical head \& neack anomalies (endoscopic) \& scans compatible with a mucormycosis previous to the inclusion and this whatever the patient incumbent pathology.~* Patient treated by liposomal amphotericin B or just before being treated~* Signature of informed consent :~  * by the patient if he is able to express their will~ * by the family or close, if the patient is unable to consent~* Inclusion in emergency clause is possible ( CPP agreement ) if the patient is incapacitated , no close is present and that the surgery is urgent~* Person affiliated to a Health Security System (beneficiary)~Exclusion Criteria:~* Pregnancy, breastfeeding~* Disseminated Mucormycosis (involvment of one site distant from the head and neck)~* Known hypersensitivity to a polyene~* Absence of documentation of mucormycosis (histological, mycological)~* Contraindication to the completion of the surgery as provided in this protocol~* Patient is the subject of a guardianship or tutelage measure

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Multiple Surgeries (Type: EXPERIMENTAL): Patients undergoing transnasal endoscopic surgery

Based on this trial design, predict the completion outcome and termination type (if applicable).